SEGA is characteristically seen in patients with TSC, an autosomal dominant phacomatosis due to inactivating variants in TSC1 or TSC2, genes that encode for inhibitors of the mammalian target of rapamycin (mTOR). The gene discussed is TSC2; the disease is tuberous sclerosis.